scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

Core Viewpoint - scPharmaceuticals Inc. is set to host a conference call on August 7, 2025, to discuss its Q2 2025 financial results and provide a business update [1]. Company Overview - scPharmaceuticals is focused on revolutionizing cardiorenal healthcare through patient-centric innovations [1][3]. - The company's mission emphasizes advancing cardiorenal care with innovative, integrated treatments that address unmet patient needs [3]. - scPharmaceuticals aims to be a leading advocate for patient-centric cardiorenal care, promoting global health improvements through specialized, multidisciplinary approaches [4]. - The company is headquartered in Burlington, MA, and is expanding its reach with integrated therapies and products to improve patient lives [4].